Fresh Tracks Therapeutics Inc. (FRTX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Fresh Tracks Therapeutics...

    NASDAQ: FRTX · Real-Time Price · USD
    0.94
    0.00 (0.00%)
    At close: Feb 28, 2025, 12:19 PM

    Fresh Tracks Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Cash & Equivalents
    		 10.87M 12.02M 8.95M 10.76M 8.68M 11.25M 14.48M 17.29M 26.88M 21.38M 24.41M 34.78M
    Short-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a 61K 64K 64K 77K 181K -96K -117K -137K -158K -73K
    Receivables
    		 45K n/a 245K 265K 504K 681K 510K 92K 125K n/a n/a n/a
    Inventory
    		 n/a n/a 443K 777K n/a 2.33M 3.25M 3.3M -125K n/a n/a n/a
    Other Current Assets
    		 94K 305K 73K 7K 124K 7K 7K 8K 59K n/a n/a n/a
    Total Current Assets
    		 11.55M 13.01M 9.71M 11.81M 10.08M 14.27M 18.25M 20.69M 29.6M 24.05M 28.91M 38.78M
    Property-Plant & Equipment
    		 34K 44K 72K 90K 124K 99K 75K 96K 117K 137K 158K 73K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 34K 44K 133K 154K 188K 176K 256K 96K 117K 137K 158K 73K
    Total Assets
    		 11.59M 13.06M 9.84M 11.97M 10.27M 14.45M 18.51M 20.79M 29.72M 24.19M 29.07M 38.85M
    Account Payables
    		 406K 609K 256K 635K 571K 1.44M 1.26M 2.98M 1.6M 1.34M 2.51M 4.56M
    Deferred Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 111K
    Other Current Liabilities
    		 1.25M 373K 920K 731K 1.32M 1.41M 1.02M 775K 1.86M 1.25M 978K 685K
    Total Current Liabilities
    		 1.66M 2.11M 1.85M 2.1M 3.08M 3.22M 2.87M 4.74M 4.81M 4.2M 6.68M 9.38M
    Long-Term Debt
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 326K
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a -18K -36K n/a
    Total Long-Term Liabilities
    		 n/a n/a n/a 663K n/a 1.46M 1.3M 3.04M 1.67M 18K 36K 326K
    Total Liabilities
    		 1.66M 2.11M 1.85M 2.1M 3.08M 3.22M 2.87M 4.74M 4.81M 4.22M 6.72M 9.71M
    Total Debt
    		 n/a n/a 19K 28K 49K 18K 36K 53K 69K 73K 86K 489K
    Book Value
    		 9.93M 10.95M 7.99M 9.87M 7.19M 11.22M 15.64M 16.05M 24.91M 19.97M 22.35M 29.14M
    Book Value Per Share
    		 1.68 1.85 1.35 2.63 2.39 3.86 5.89 6.05 10.37 10.78 14.62 21.44
    Common Stock
    		 60K 59K 59K 59K 30K 30K 1.21M 1.19M 1.19M 887K 719K 672K
    Retained Earnings
    		 -172.16M -170.93M -173.03M -170.75M -166.47M -161.94M -155.92M -154.78M -145.37M -139.3M -126.05M -114.9M
    Comprehensive Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Shareholders Equity
    		 9.93M 10.95M 7.99M 9.87M 7.19M 11.22M 15.64M 16.05M 24.91M 19.97M 22.35M 29.14M
    Total Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist